Harvard Bioscience Inc. (HBIO)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
2.60-0.10 (-3.70%)
At close: 4:00 PM EDT
People also watch:
LMNXGTXIBRKRARQLHSKA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open2.69
Prev Close2.70
Bid2.58 x 200
Ask3.20 x 10000
Day's Range2.58 - 2.72
52wk Range2.41 - 4.70
1y Target EstN/A
Market Cap89.21M
P/E Ratio (ttm)-4.53
Beta0.88
Volume88,288
Avg Vol (3m)152,751
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • American City Business Journals10 days ago

    EXCLUSIVE: UW president lays out vision for Global Innovation Exchange

    When the University of Washington and China's Tsinghua University open a first-of-its-kind technology graduate program in Bellevue next fall, it won't be a copy of either school. “A lot of universities have done a mini version – a mini Harvard or mini Yale someplace in Singapore or China. This is a very different thing,” University of Washington President Ana Mari Cauce said.

  • Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
    Capital Cube16 days ago

    Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016

    Categories: Yahoo Finance Click here to see latest analysis Harvard Bioscience, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Harvard Bioscience, Inc. – PerkinElmer, Inc., Bruker Corporation, Thermo Fisher Scientific Inc., Johnson & Johnson, Bio-Rad Laboratories, Inc. Class A, Becton, Dickinson and Company, General Electric ... Read more (Read more...)

  • Associated Presslast month

    Harvard Bioscience reports 2Q loss

    The Holliston, Massachusetts-based company said it had a loss of 2 cents per share. Earnings, adjusted for one-time gains and costs, came to 3 cents per share. The medical instruments maker posted revenue ...